The pre-seed round saw support from Entourage Ventures, Anacura, and Qbic Fund.
Polysense develops an AI-native platform that automates in-line quality control for food manufacturers using real-time imaging and synthetic data.
The fresh capital will finance HEALANT's commercial launch, scale up its manufacturing process, and expand its go-to-market and partnership operations.
The round was led by Motive Partners and supported by F Capital, Entourage, Syndicate One, and 100IN.
The seed round was led by LIFTT, with participation from AIF, PINC, VIB, Corteva via Corteva Catalyst, and Maia Ventures.
The Series A round was led by Astaia, with support from SFPIM and the European Innovation Council Fund.
Elephant led the €11.5 million Series A, with Entourage VC also backing.
The program includes a €140 million EU guarantee provided by the European Commission and €21 million in EU investment grants.